ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

NVNO enVVeno Medical Corporation

5.14
0.14 (2.80%)
May 13 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 35,533
Bid Price 4.92
Ask Price 5.24
News -
Day High 5.2199

Low
2.51

52 Week Range

High
6.97

Day Low 4.92
Share Name Share Symbol Market Stock Type
enVVeno Medical Corporation NVNO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.14 2.80% 5.14 15:48:55
Open Price Low Price High Price Close Price Previous Close
5.03 4.92 5.2199 4.92 5.00
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
352 35,533 US$ 5.07 US$ 180,113 - 2.51 - 6.97
Last Trade Type Quantity Price Currency
15:43:44 formt 200 US$ 5.14 USD

enVVeno Medical Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
138.23M 13.32M - 0 -23.52M -1.77 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

enVVeno Medical News

Date Time Source News Article
3/06/202407:40Edgar (US Regulatory)Form 8-K - Current report
12/07/202316:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/07/202316:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/07/202316:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/07/202316:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/07/202316:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/07/202316:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/07/202315:05Edgar (US Regulatory)Form 8-K - Current report
11/16/202307:45Edgar (US Regulatory)Form 8-K - Current report
11/05/202323:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
11/03/202315:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statements
10/26/202316:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NVNO Message Board. Create One! See More Posts on NVNO Message Board See More Message Board Posts

Historical NVNO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.055.29994.925.0343,2680.091.78%
1 Month5.115.604.575.0655,3540.030.59%
3 Months5.156.974.575.80127,075-0.01-0.19%
6 Months4.586.973.405.16103,7620.5612.23%
1 Year4.336.972.514.8981,3840.8118.71%
3 Years10.3810.752.515.4454,186-5.24-50.48%
5 Years10.3810.752.515.4454,186-5.24-50.48%

enVVeno Medical Description

enVVeno Medical Corp is a medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its lead product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).

Your Recent History

Delayed Upgrade Clock